Latest Period
Q2 2026
Security Snapshot
Novonesis Novozymes B - Common Stock - Foreign Institutional Ownership
CUSIP: 00B798FW0
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
2
Shares (Excl. Options)
252,884
Price
$63.10
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock - Foreign
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 252,884
- Total 13F value
- $15,955,750
- Portfolio coverage rank
- 0%
- Share change
- +249,754
- Value change
- +$15,758,226
- Number of holders
- 2
- SEC-reported price per share
- $63.10
Latest holder snapshot
4 signals
Issuer context
Names, identifiers, and filing context for this profile.
1 identity field
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- 00B798FW0 - Novonesis Novozymes B - Common Stock - Foreign is tracked under CUSIP 00B798FW0.
- 2 institutions reported positions in Q2 2026.
- Schedule 13D/13G significant owner rows are not currently available.
Change
- Holder count moved from 1 to 2 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $185,000 to $15,955,750.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 2 institutions filings for Q2 2026.
Security key
00B798FW0
Latest holder period
Q2 2026
13F holders
2
13D/G owners
0
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00B798FW0:
As of 30 Jun 2026, 2 institutional investors reported holding 252,884 shares of Novonesis Novozymes B - Common Stock - Foreign.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
35
Latest
Q2 2026
Rows shown
1-25 of 35
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 252,884 | $15,955,750 | +$15,758,226 | $63.10 | 2 |
| 2026 Q1 | 3,130 | $185,000 | +$5,438 | $59.11 | 1 |
| 2025 Q4 | 3,038 | $194,926 | -$1,732 | $64.16 | 1 |
| 2025 Q3 | 3,065 | $187,572 | +$187,572 | $61.20 | 1 |
| 2023 Q3 | 0 | $0 | -$708,013 | $63.10 | 0 |
| 2023 Q2 | 15,200 | $708,013 | $46.58 | 1 | |
| 2023 Q1 | 15,200 | $777,896 | +$777,896 | $51.18 | 1 |
| 2021 Q1 | 0 | $0 | -$1,314,237 | $63.10 | 0 |
| 2020 Q4 | 22,876 | $1,314,237 | $57.45 | 1 | |
| 2020 Q3 | 22,876 | $1,441,158 | +$27,152 | $63.00 | 1 |
| 2020 Q2 | 22,445 | $1,297,125 | $57.79 | 1 | |
| 2020 Q1 | 22,445 | $1,020,797 | -$170,550 | $45.48 | 1 |
| 2019 Q4 | 26,195 | $1,282,796 | $48.97 | 1 | |
| 2019 Q3 | 26,195 | $1,101,570 | $42.05 | 1 | |
| 2019 Q2 | 26,195 | $1,223,419 | $46.70 | 1 | |
| 2019 Q1 | 26,195 | $1,205,609 | +$129,789 | $46.02 | 1 |
| 2018 Q4 | 23,375 | $1,041,642 | $44.56 | 1 | |
| 2018 Q3 | 23,375 | $1,283,735 | $54.92 | 1 | |
| 2018 Q2 | 23,375 | $1,185,691 | $50.72 | 1 | |
| 2018 Q1 | 23,375 | $1,204,829 | $51.54 | 1 | |
| 2017 Q4 | 23,375 | $1,336,436 | $57.17 | 1 | |
| 2017 Q3 | 23,375 | $1,199,794 | $51.33 | 1 | |
| 2017 Q2 | 23,375 | $1,021,589 | $43.70 | 1 | |
| 2017 Q1 | 23,375 | $929,251 | +$825,890 | $39.75 | 1 |
| 2016 Q4 | 2,600 | $89,807 | -$16,925,193 | $34.54 | 1 |